Breakthrough In Two Pages: FDA Offers Preliminary Advice
This article was originally published in The Pink Sheet Daily
Executive Summary
Agency now allows sponsors of potential breakthrough therapies to request preliminary advice, but sponsors may not necessarily want to use it.